UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 36

Sortiert nach

Intravitreal Aflibercept for Diabetic Macular Edema

Ophthalmology (Rochester, Minn.), 2014-11, Vol.121 (11), p.2247-2254

2014

Volltextzugriff (PDF)

Three-Year, Randomized, Sham-Controlled Trial of Dexamethasone Intravitreal Implant in Patients with Diabetic Macular Edema

Ophthalmology (Rochester, Minn.), 2014-10, Vol.121 (10), p.1904-1914

2014

Volltextzugriff (PDF)

Seven-Year Outcomes in Ranibizumab-Treated Patients in ANCHOR, MARINA, and HORIZON

Ophthalmology (Rochester, Minn.), 2013-11, Vol.120 (11), p.2292-2299

2013

Volltextzugriff (PDF)

Intravitreal Aflibercept Injection for Macular Edema Due to Central Retinal Vein Occlusion

Ophthalmology (Rochester, Minn.), 2014-07, Vol.121 (7), p.1414-1420.e1

2014

Volltextzugriff (PDF)

Dexamethasone Intravitreal Implant in Combination with Laser Photocoagulation for the Treatment of Diffuse Diabetic Macular Edema

Ophthalmology (Rochester, Minn.), 2013-09, Vol.120 (9), p.1843-1851

2013

Volltextzugriff (PDF)

Fellow Eye Comparisons for 7-Year Outcomes in Ranibizumab-Treated AMD Subjects from ANCHOR, MARINA, and HORIZON (SEVEN-UP Study)

Ophthalmology (Rochester, Minn.), 2016-06, Vol.123 (6), p.1269-1277

2016

Volltextzugriff (PDF)

A Phase IIIb Study to Evaluate the Safety of Ranibizumab in Subjects with Neovascular Age-related Macular Degeneration

Ophthalmology (Rochester, MN), 2009-09, Vol.116 (9), p.1731-1739

2009

Volltextzugriff (PDF)

Treatment of Diabetic Macular Edema with an Inhibitor of Vascular Endothelial-Protein Tyrosine Phosphatase That Activates Tie2

Ophthalmology (Rochester, Minn.), 2015-03, Vol.122 (3), p.545-554

2015

Volltextzugriff (PDF)

Subgroup Analysis of the MARINA Study of Ranibizumab in Neovascular Age-Related Macular Degeneration

Ophthalmology (Rochester, Minn.), 2007-02, Vol.114 (2), p.246-252

2007

Volltextzugriff (PDF)

Comprehensive Review of Ocular and Systemic Safety Events with Intravitreal Aflibercept Injection in Randomized Controlled Trials

Ophthalmology (Rochester, Minn.), 2016-07, Vol.123 (7), p.1511-1520

2016

Volltextzugriff (PDF)

A Phase I, Single Ascending Dose Study of GEM103 (Recombinant Human Complement Factor H) in Patients with Geographic Atrophy

Ophthalmology science (Online), 2022-06, Vol.2 (2), p.100154-100154, Article 100154

2022

Volltextzugriff (PDF)

Randomized Trial of Treat and Extend Ranibizumab with and without Navigated Laser for Diabetic Macular Edema

Ophthalmology (Rochester, Minn.), 2017-01, Vol.124 (1), p.74-81

2017

Volltextzugriff (PDF)

Outcomes of cataract surgery in patients with neovascular age-related macular degeneration in the era of anti-vascular endothelial growth factor therapy

Journal of cataract and refractive surgery, 2012-04, Vol.38 (4), p.677-682

2012

Volltextzugriff (PDF)

Intravitreal Aflibercept for Diabetic Macular Edema

Ophthalmology (Rochester, Minn.), 2016-11, Vol.123 (11), p.2376-2385

2016

Volltextzugriff (PDF)

Intravitreal Aflibercept Injection in Diabetic Macular Edema Patients with and without Prior Anti–Vascular Endothelial Growth Factor Treatment

Ophthalmology (Rochester, Minn.), 2016-04, Vol.123 (4), p.850-857

2016

Volltextzugriff (PDF)

Outcomes with As-Needed Ranibizumab after Initial Monthly Therapy

Ophthalmology (Rochester, Minn.), 2015-12, Vol.122 (12), p.2504-2513.e1

2015

Volltextzugriff (PDF)

Intravitreal Aflibercept for Macular Edema Following Branch Retinal Vein Occlusion

Ophthalmology (Rochester, Minn.), 2016-02, Vol.123 (2), p.330-336

2016

Volltextzugriff (PDF)

Intravitreal Aflibercept for Diabetic Macular Edema

Ophthalmology (Rochester, Minn.), 2015-10, Vol.122 (10), p.2044-2052

2015

Volltextzugriff (PDF)

Intravitreal Aflibercept for Macular Edema Following Branch Retinal Vein Occlusion

Ophthalmology (Rochester, Minn.), 2015-03, Vol.122 (3), p.538-544

2015

Volltextzugriff (PDF)

Evolving strategies in the management of diabetic macular edema: clinical trials and current management

Canadian journal of ophthalmology, 2013-02, Vol.48 (1), p.22-30

2013

Volltextzugriff (PDF)

Long-term Outcomes in Patients with Retinal Vein Occlusion Treated with Ranibizumab

Ophthalmology (Rochester, Minn.), 2014, Vol.121 (1), p.209-219

2014

Volltextzugriff (PDF)

Complement Factor H Polymorphism in Age-Related Macular Degeneration

Ophthalmology (Rochester, Minn.), 2007-07, Vol.114 (7), p.1327-1331

2007

Volltextzugriff (PDF)

Long-term Outcomes of Ranibizumab Therapy for Diabetic Macular Edema: The 36-Month Results from Two Phase III Trials

Ophthalmology (Rochester, Minn.), 2013-10, Vol.120 (10), p.2013-2022

2013

Volltextzugriff (PDF)

Verteporfin plus Ranibizumab for Choroidal Neovascularization in Age-Related Macular Degeneration

Ophthalmology (Rochester, Minn.), 2012-05, Vol.119 (5), p.1001-1010

2012

Volltextzugriff (PDF)

Reply

Ophthalmology (Rochester, Minn.), 2016, Vol.123 (10), p.e60-e61

2016

Volltextzugriff (PDF)

1 – 25 von 36

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(35)
Mit Volltextzugriff
(33)

Publikationsform

Artikel
(35)
Buchkapitel
(1)

Sprache

Englisch
(36)
Japanisch
(10)

Erscheinungsjahr

n.n

Thema

Ophthalmology
(30)
Life Sciences & Biomedicine
(23)
Science & Technology
(23)
Humans
(20)
Female
(16)
Male
(16)
Middle Aged
(13)
Aged
(12)
Adult
(10)
Aged, 80 And Over
(10)
Vascular Endothelial Growth Factor A - Antagonists & Inhibitors
(9)
Visual Acuity - Physiology
(9)
Treatment Outcome
(8)
Angiogenesis Inhibitors - Therapeutic Use
(7)
Biological And Medical Sciences
(7)
Diabetic Retinopathy - Drug Therapy
(7)
Intravitreal Injections
(7)
Macular Edema - Drug Therapy
(7)
Medical Sciences
(7)
Double-Blind Method
(5)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Intravitreal Aflibercept for Diabetic Macular Edema

Three-Year, Randomized, Sham-Controlled Trial of Dexamethasone Intravitreal Implant in Patients with Diabetic Macular Edema

Seven-Year Outcomes in Ranibizumab-Treated Patients in ANCHOR, MARINA, and HORIZON

Intravitreal Aflibercept Injection for Macular Edema Due to Central Retinal Vein Occlusion

Dexamethasone Intravitreal Implant in Combination with Laser Photocoagulation for the Treatment of Diffuse Diabetic Macular Edema

Fellow Eye Comparisons for 7-Year Outcomes in Ranibizumab-Treated AMD Subjects from ANCHOR, MARINA, and HORIZON (SEVEN-UP Study)

A Phase IIIb Study to Evaluate the Safety of Ranibizumab in Subjects with Neovascular Age-related Macular Degeneration

Treatment of Diabetic Macular Edema with an Inhibitor of Vascular Endothelial-Protein Tyrosine Phosphatase That Activates Tie2

Subgroup Analysis of the MARINA Study of Ranibizumab in Neovascular Age-Related Macular Degeneration

Comprehensive Review of Ocular and Systemic Safety Events with Intravitreal Aflibercept Injection in Randomized Controlled Trials

A Phase I, Single Ascending Dose Study of GEM103 (Recombinant Human Complement Factor H) in Patients with Geographic Atrophy

Randomized Trial of Treat and Extend Ranibizumab with and without Navigated Laser for Diabetic Macular Edema

Outcomes of cataract surgery in patients with neovascular age-related macular degeneration in the era of anti-vascular endothelial growth factor therapy

Intravitreal Aflibercept for Diabetic Macular Edema

Intravitreal Aflibercept Injection in Diabetic Macular Edema Patients with and without Prior Anti–Vascular Endothelial Growth Factor Treatment

Outcomes with As-Needed Ranibizumab after Initial Monthly Therapy

Intravitreal Aflibercept for Macular Edema Following Branch Retinal Vein Occlusion

Intravitreal Aflibercept for Diabetic Macular Edema

Intravitreal Aflibercept for Macular Edema Following Branch Retinal Vein Occlusion

Evolving strategies in the management of diabetic macular edema: clinical trials and current management

Long-term Outcomes in Patients with Retinal Vein Occlusion Treated with Ranibizumab

Complement Factor H Polymorphism in Age-Related Macular Degeneration

Long-term Outcomes of Ranibizumab Therapy for Diabetic Macular Edema: The 36-Month Results from Two Phase III Trials

Verteporfin plus Ranibizumab for Choroidal Neovascularization in Age-Related Macular Degeneration

Reply

Suchergebnisse filtern